GlassScriptPhysician profile
Joseph P Luke
NPI 1881653871
$13,945.05
in general payments reported to CMS, 2019-2025
12 companies · $30.72 in 2025
The $30.72 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $4,544 · 2021: $107 · 2022: $4,873 · 2023: $2,608 · 2024: $1,358 · 2025: $30.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,000 · Food and Beverage: $1,452 · Travel and Lodging: $528 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,000.00 |
| Food and Beverage | $1,452.03 |
| Travel and Lodging | $528.08 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,838.61 | 2020-2024 | Da Vinci Surgical System, Davinci Xi |
| W. L. Gore & Associates, INC. | $449.35 | 2023 | Gore Bio-A Tissue Reinforcement |
| Republic Spine | $300.16 | 2019 | |
| Stryker Corporation | $125.00 | 2019 | |
| Merck Sharp & Dohme LLC | $71.11 | 2021-2024 | Keytruda, Lynparza |
| Olympus America INC. | $36.95 | 2023-2024 | Olympus, Olympus |
| Vertex Pharmaceuticals Incorporated | $30.72 | 2025 | |
| Tela Bio, INC. | $24.49 | 2024 | Ovitex 2s |
| Hologic Sales and Service, LLC | $21.84 | 2022 | |
| Integra Lifesciences Corporation | $16.81 | 2023 | Integra, Surgimend, Omnigraft |
| Teleflex LLC | $15.27 | 2020 | |
| Ethicon US, LLC | $14.74 | 2023 | Megadyne |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Luke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.